Position in VIR
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$6,821,821
+$3,116,604 QoQ
Shares Held
761,364
+23.9% QoQ
Ownership
0.451%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,450,872,574 across 330 Biotechnology names. VIR ranks #68 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,726,993 | $588,750,729 | |
| 2 | INCY |
Incyte Corp
|
3,651,532 | $343,682,191 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
5,682,783 | $229,072,982 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
421,688 | $188,300,559 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
819,374 | $154,902,654 | |
| 6 | GMAB |
Genmab A/S
|
4,414,550 | $118,442,376 | |
| 7 | INVA |
Innoviva, Inc.
|
4,055,632 | $94,496,225 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
1,036,495 | $64,988,236 |
All Filings in VIR
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,821,821 | 761,364 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,705,217 | 614,464 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,664,141 | 1,167,100 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,365,080 | 1,064,500 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $7,260,192 | 1,120,400 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $9,083,984 | 1,237,600 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $8,855,427 | 1,182,300 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $11,834,330 | 1,329,700 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $13,737,293 | 1,356,100 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $13,023,676 | 1,294,600 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $12,690,728 | 1,354,400 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $28,653,493 | 1,168,100 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $27,004,835 | 1,160,500 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $26,788,104 | 1,058,400 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $29,160,884 | 1,512,494 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $14,324,328 | 562,400 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,427,968 | 94,400 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,424,273 | 57,900 | Shares | Sole | 2022-02-11 | |
| 2021-06-30 | $3,787,222 | 80,102 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $2,004,795 | 58,500 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||